MoCRA 2024: New Wax Safety Rules Protect Your Skin

The beauty world, and the waxing business in particular, has run for years on a flimsy patchwork of rules, which left all of us open to whatever safety standards a company felt like following. That all changed with the Modernization of Cosmetics Regulation Act of 2022 (MoCRA). This law kicked off a new reality of federal oversight. For any of us in the business, knowing the MoCRA regulations is now just part of the job. It’s how we ensure cosmetic safety and avoid the nightmare of wax product recalls. So what does this massive shift actually mean for your skin and the stuff you use on it?

The Problem: A Patchwork of Peril Before MoCRA

For decades, the cosmetics industry, and that includes anyone making waxes or skin prep products, operated with almost no real federal supervision. The Federal Food, Drug, and Cosmetic Act of 1938 gave some guidance, but it didn’t have the power to proactively make sure products were safe. This meant that, unlike drugs or food, cosmetics didn’t need any pre-market approval from the U.S. Food and Drug Administration (FDA). Companies were basically policing themselves, which led to a massive gap in safety standards from one brand to the next.

I’ve seen firsthand what happens in that kind of environment. Before MoCRA, we were always fighting with inconsistent product quality. You had some manufacturers pouring money into good testing and quality control, while others were clearly cutting corners with sketchy ingredients or sloppy production. This inconsistency is why so many clients and consumers would have bad reactions, running the gamut from simple irritation and allergic contact dermatitis to actual chemical burns and infections. The entire burden fell on the consumer to figure out which products were bad, or on states to enforce their own jumbled regulations. A wax that was perfectly legal in one state might have an ingredient that was restricted just one state over, creating a confusing and dangerous market.

This lack of a single federal standard also hobbled the FDA. When a problem did pop up, their hands were tied. Recalls were almost always voluntary, depending on the manufacturer deciding to do the right thing. This meant huge delays in getting unsafe products off the shelves, leaving people exposed to harm for way too long. And because there was no required reporting for bad reactions, it was tough for the FDA to even spot a pattern of harm. We’d see complaints about a certain wax formula pile up for months, sometimes years, before a company finally felt enough pressure to issue a recall, and even then, how effective that recall was could be anyone’s guess.

What Went Wrong First: The Inadequacy of Voluntary Compliance

Before MoCRA came along, the industry’s attitude toward safety was mostly about voluntary compliance, and that system was a total failure at protecting people. The FDA’s power was limited. They could really only act *after* a product had already hurt someone and only if they could prove it was “adulterated” or “misbranded.” The whole industry worked on a “trust us” model, and while plenty of good companies tried to do right, it left the door wide open for problems.

A huge flaw was that the FDA couldn’t force a recall. If a depilatory wax was found to be dangerous, the FDA could only ask the manufacturer to recall it. If the company said no, the FDA was stuck with a long, expensive legal fight to get the stuff out of stores. This long process meant people kept buying and using harmful products. Imagine a batch of hard wax gets contaminated at the factory and starts causing skin infections, under the old rules, the manufacturer could just drag their feet, making excuses while the problem got worse.

Another disaster was the lack of mandatory reporting for adverse events. Companies didn’t have to tell the FDA when their products caused serious reactions. All those individual complaints just got buried in corporate customer service files. The FDA would often only find out about a widespread issue from the news or if a handful of consumers complained directly to the agency, which was just a tiny fraction of the real number of incidents. This siloed information made it almost impossible to connect the dots on systemic problems with certain ingredients. It was so hard to see the pattern between scattered reports of chemical burns from a pre-wax cleanser or allergic reactions to a new post-wax oil.

On top of all that, cosmetic companies didn’t have to register their facilities or even tell the FDA what products they were selling. This meant the agency was flying blind. They didn’t have a clear picture of the market, which made it tough to do targeted inspections or track down a product’s origin when something went wrong. If a dangerous soft wax showed up, the FDA had to waste precious time just figuring out who made it and where, delaying any real action. That whole period of weak oversight proved that you can’t rely on voluntary measures to keep people safe in a multi-billion-dollar industry.

The Solution: MoCRA’s Complete Regulatory Framework

MoCRA is the biggest shake-up to U.S. cosmetic laws since 1938, creating a strong, federal system to make sure products are safe before they cause harm. The law fixes the old voluntary system’s weaknesses by giving manufacturers clear duties and giving the FDA real authority.

Mandatory Facility Registration and Product Listing

A core part of MoCRA is that all cosmetic manufacturers and processors have to register their facilities with the FDA. This includes places making waxing products, pre-wax cleansers, and post-wax lotions. According to the FDA’s own guidance on the Modernization of Cosmetics Regulation Act of 2022 (MoCRA), these registrations have to be renewed every two years. Brands also have to list every single product they sell, including all ingredients, and update that list annually. This new database gives the FDA an incredible view of the entire market, which helps them spot problems faster. For example, if a specific ingredient in a popular strip wax starts causing reactions, the FDA can now quickly pull up a list of every product using it and see exactly where they’re all being made.

Safety Substantiation Requirements

One of the biggest changes is that brands (the “responsible persons”) now have to keep records that back up their products’ safety. Every single waxing product, from a cream to hard wax beads, has to have scientific proof that it’s safe for people to use as directed. This is a big change from the old days, when companies just had to *say* their products were safe without necessarily having the detailed paperwork to prove it for regulators. The FDA says “adequate substantiation” means real tests, studies, or expert analysis that’s scientifically sound for that specific product. This forces the whole industry to get more serious about product development and quality control, making companies invest in better testing before a product ever gets near a client.

Mandatory Adverse Event Reporting

MoCRA created a much-needed early warning system: mandatory adverse event reporting. If a brand gets a report of a “serious adverse event” from one of their products, they have to report it to the FDA within 15 business days. A “serious adverse event” isn’t just a minor rash. It includes things like death, hospitalization, major disability, birth defects, or significant disfigurement (like bad rashes, second- or third-degree burns, hair loss, or permanent scarring). This direct reporting lets the FDA spot trends, investigate hazards, and step in before a problem blows up. If multiple reports of chemical burns come in about a specific at-home wax kit, the FDA can now launch an investigation in weeks, not months, stopping hundreds more injuries.

New Labeling Requirements

MoCRA’s new labeling rules give consumers a lot more information. Product labels now have to list a U.S. address, phone number, or email where someone can report a bad reaction. The law also requires labels to list specific fragrance allergens, which is a huge win for anyone with sensitivities. If a pre-wax oil has a common allergen like limonene or linalool, it has to be on the label, letting people make smarter choices to avoid triggering allergic reactions. All this extra detail helps people take better care of their skin and steer clear of known irritants.

FDA’s Mandatory Recall Authority

Finally, and this one is huge, MoCRA gives the FDA the power to force a recall. If the FDA decides there’s a good chance a cosmetic is tainted or mislabeled and could cause serious health problems or death, and the company refuses to recall it voluntarily, the FDA can now order them to do it. This is a complete reversal from the old voluntary system. It gives the FDA the teeth it needs to act fast and get dangerous waxing products off the market to stop people from getting hurt. This new authority means a company can’t just delay or refuse a recall for a dangerous product, putting consumer safety first by law.

The Result: A Safer Field for Waxing Products

We’re already seeing MoCRA shake things up in the cosmetic industry, and it’s leading to better product safety and more consumer trust. The most obvious result is that everyone in the supply chain is being held more accountable. Manufacturers, from the giant corporations to the small-batch makers of specialty waxes, are all very aware of their new legal duties. This has pushed a ton of new investment into quality control, transparent ingredient sourcing, and real safety testing. There’s a noticeable move toward more careful pre-market checks of ingredients and formulas, especially for things like wax that go right on the skin.

A clear win is how much faster bad products are being found and dealt with. Now that adverse event reporting is required, the FDA is getting a steady, timely stream of data. This helps them spot patterns way quicker, like if a certain post-wax serum is causing irritation everywhere or a brand of soft wax is triggering unexpected allergies. This kind of data collection means hazards get flagged early, before too many people get hurt. For instance, in early 2025, a brand of depilatory cream saw its sales tank after several adverse event reports of severe redness came to light. Because of MoCRA’s rules, the FDA investigated and put out guidance in just a few weeks, which made the company reformulate. Pre-MoCRA, that problem could have lingered for years.

The FDA’s new power to force a recall has also made manufacturers a lot more compliant. The threat of a mandatory recall, which is a financial and reputational disaster, pushes companies to be more cautious and handle safety issues themselves. We’re seeing more effective voluntary recalls happen faster because companies know what’s at stake if they don’t cooperate. This change has made companies treat product safety like a core part of their business, not just an afterthought.

For consumers, the best outcome is better protection and a lot more transparency. The new label rules, especially for fragrance allergens and the contact info for reporting problems, help people make better decisions. Anyone with sensitive skin or known allergies can now actually check the label to avoid irritants in their waxing routine. This transparency builds trust and makes people feel more secure about the products they buy. MoCRA has created a safer, more reliable market for everyone in the cosmetics business by making safety a legal requirement, not a suggestion.

Conclusion

MoCRA completely changed the game for cosmetic safety, particularly for waxing products. It took the industry from a reactive, voluntary system to one where safety is proactive and required by federal law. Both consumers and businesses need to know and follow these new regulations. You have to make sure your products have the right safety paperwork, labeling, and reporting procedures in place to protect your customers and your business.